Search

Can anybody spare a dime for science? With the usual funding avenues blocked development-stage companies are turning to research charities.

GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.

Private equity and venture capital investment by UK-based firms in 2008 fell below £20 billion for the first time since 2005, says a new report.

The number of Technology, Media & Telecoms (TMT) businesses with sufficient access to funding has halved in the past year, according to new research.

Physicist Andre Geim of Manchester University has been awarded the annual €750,000 Körber Foundation European Science award for the discovery of graphene.

Liverpool University has been awarded £3.5 million to improve knowledge transfer capabilities between academic researchers and industrial partners.